Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Global Medical Carts Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
12:00am, Saturday, 17'th Oct 2020
Medical Carts market will register an incremental spend of about $1 billion, growing at a CAGR of 8.45% during the five-year forecast period.
mHealth Services Market overview 2020, In-depth analysis with Impact of COVID-19, Types, Opportunities, Revenue and Forecast 2026
11:15am, Tuesday, 06'th Oct 2020
Oct 06, 2020 (Heraldkeepers) --
New York, October 6, 2020: The mHealth services market is expected to exceed more than US$ 158.0 Billion by 2024 from USD...
CORRECTING and REPLACING Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group’s 340B Business to Omnicell
12:00am, Saturday, 03'rd Oct 2020
Headline of release should read: Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group’s 340B Business to Omnicell (instead of: Blue Wol
Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group to Omnicell
12:00am, Friday, 02'nd Oct 2020
Today, Blue Wolf Capital Partners (“Blue Wolf”), a New York-based private equity firm, announced the completion of the sale of Pharmaceutical Strategi
Global Medical Carts Market Procurement Intelligence Report With COVID-19 Impact Analysis | Global Forecasts, 2020-2024 | SpendEdge
12:00am, Wednesday, 30'th Sep 2020
Global Medical Carts market will register an incremental spend of about $1 billion, growing at a CAGR of 8.45% during the five-year forecast period.
Captrust Financial Advisors Makes New Investment in Omnicell, Inc. (NASDAQ:OMCL)
07:15am, Thursday, 24'th Sep 2020
Captrust Financial Advisors acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 1,253 shares of th
Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)
12:00am, Wednesday, 23'rd Sep 2020
Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)
Great West Life Assurance Co. Can Has $3.67 Million Holdings in Omnicell, Inc. (NASDAQ:OMCL)
06:20am, Tuesday, 22'nd Sep 2020
Great West Life Assurance Co. Can trimmed its stake in Omnicell, Inc. (NASDAQ:OMCL) by 5.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commissio
Randall A. Lipps Sells 1,400 Shares of Omnicell, Inc. (NASDAQ:OMCL) Stock
07:48am, Friday, 18'th Sep 2020
Omnicell, Inc. (NASDAQ:OMCL) CEO Randall A. Lipps sold 1,400 shares of the stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $75.01, for a to
Omnicell (OMCL) Hurt by Coronavirus-Led Lower Product Booking
02:51pm, Tuesday, 18'th Aug 2020
Omnicell (OMCL) is currently witnessing slowdown in purchasing decisions by hospitals.
Omnicell, Pharmaceutical Strategies Enter Acquisition Deal
01:10pm, Monday, 17'th Aug 2020
Omnicell (OMCL) expands pharmacy supply chain capabilities for better management of 340B programs through the buyout of PSG's 340B Link business.
Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding
12:00pm, Monday, 17'th Aug 2020
Peninsula Regional Medical Center Extends Partnership with Omnicell to Enhance Safety and Efficiency in Sterile Compounding
Did Hedge Funds Make The Right Call On Omnicell, Inc. (OMCL) ?
02:02pm, Wednesday, 12'th Aug 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
12:00pm, Wednesday, 12'th Aug 2020
Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Omnicell, Inc.'s (NASDAQ:OMCL) Popularity With Investors Is Clear
04:04pm, Tuesday, 11'th Aug 2020
With a price-to-earnings (or "P/E") ratio of 59.1x Omnicell, Inc. (NASDAQ:OMCL) may be sending very bearish signals at...
